Relateret til det foregående, mere omfattende kommentarer fra Redeye
… At the time of the IPO, Skwortsow owned approximately 23% of the shares, while Molin held around 25%. Skwortsow has not been active in Physitrack for quite some time and has gradually reduced his ownership, while Molin’s ownership has remained intact. By the end of July 2025, Skwortsow’s stake had declined to around 8%. Given his continuous selling, combined with the relatively limited liquidity in the share, an overhang effect has lingered on the stock. With this latest transaction, that overhang now appears largely removed. Since Skwortsow no longer has operational commitments to the company, we see no drama in a founder exiting to pursue new ventures.